Product Details

Purevax RC Lyophilisate and Solvent for Suspension for Injection

• MA holder: Boehringer Ingelheim Vetmedica Gmbh
• VM number: 04491/5052
• Territory: Great Britain
• Associated documents:
  • View Summary of Product Characteristics
  • View Product Literature (labelling and package leaflet text)
  • View Post Authorisation Assessment
• Date of issue: 23/02/2005
• Authorisation route: National
• Active substances:
  • Feline calicivirus
  • Feline viral rhinotracheitis virus
• Controlled drug: No
• Target species:
  • Cats
• Distribution category: POM-V
• Distributors:
  • Boehringer Ingelheim Animal Health UK Limited